Drug Maker Describes Changes in Marketing
- Share via
SUMMIT, N.J. — Drug maker Ciba-Geigy Corp. on Monday announced marketing changes as a federal grand jury investigated the company’s tactics.
The grand jury is probing the promotion of an arthritis drug, Voltarin, said company spokeswoman Cathy Kernen. A subpoena for information on the marketing strategy was given to the company Sept. 3, Kernen said.
Ciba-Geigy made changes in their marketing techniques after meetings with the federal Food and Drug Administration earlier this year, Kernen said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
